I am a
Home I AM A Search Login

Papers of the Week

2022 Feb

Curr Pharmacol Rep



Biomarkers from Secondary Complications in Spinal Cord Injury.


Alostaz H, Cai L
Curr Pharmacol Rep. 2022 Feb; 8(1):20-30.
PMID: 36147780.


In the USA, spinal cord injury (SCI) occurs in 40 people per million every year due to events such as car accidents, falls, violence, or sports injury. Secondary complications that arise from SCI are life-threatening and should be treated as early as possible. In some cases, it is not completely obvious what complication a patient may have until it is too late. Therefore, biomarkers are required to assess the levels of secondary complications after SCI. As there are several complications that pose different warning signs, different biomarkers may be beneficial in early detection, maintenance, and long-term care for patients with SCI.